Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MRNA

Moderna Inc

Feb 12 • 02:40PM ET

39.39

-1.12 -2.76 %

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI VOO VB RSP IVV SPY VBR XBI XLV IBB

Scroll to Statements

Index	S&P 500	P/E	-	EPS (ttm)	-8.06	Insider Own	8.54%	Shs Outstand	391.00M	Perf Week	-3.62%
Market Cap	15.39B	Forward P/E	-	EPS next Y	-6.69	Insider Trans	-0.07%	Shs Float	357.38M	Perf Month	-0.53%
Enterprise Value	11.62B	PEG	-	EPS next Q	-2.54	Inst Own	70.24%	Short Float	20.01%	Perf Quarter	49.15%
Income	-3.12B	P/S	6.90	EPS this Y	15.55%	Inst Trans	-4.04%	Short Ratio	6.16	Perf Half Y	46.49%
Sales	2.23B	P/B	1.65	EPS next Y	14.62%	ROA	-22.31%	Short Interest	71.51M	Perf YTD	33.57%
Book/sh	23.86	P/C	3.42	EPS next 5Y	20.28%	ROE	-29.32%	52W High	55.20 -28.64%	Perf Year	29.00%
Cash/sh	11.53	P/FCF	-	EPS past 3/5Y	- -42.94%	ROIC	-31.11%	52W Low	22.28 76.80%	Perf 3Y	-76.73%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-43.99% 121.86%	Gross Margin	38.93%	Volatility	7.90% 8.14%	Perf 5Y	-78.56%
Dividend TTM	-	EV/Sales	5.21	EPS Y/Y TTM	-38.95%	Oper. Margin	-155.15%	ATR (14)	3.12	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.73	Sales Y/Y TTM	-56.00%	Profit Margin	-139.61%	RSI (14)	46.47	Recom	2.96
Dividend Gr. 3/5Y	- -	Current Ratio	3.93	EPS Q/Q	-1673.01%	SMA20	-10.22%	Beta	1.34	Target Price	37.63
Payout	-	Debt/Eq	0.08	Sales Q/Q	-45.44%	SMA50	8.32%	Rel Volume	0.54	Prev Close	40.51
Employees	5800	LT Debt/Eq	0.07	Earnings	Feb 13 BMO	SMA200	34.55%	Avg Volume	11.61M	Price	39.39
IPO	Dec 07, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	72.79% 10.33%	Trades		Volume	5,029,627	Change	-2.76%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-28-26	Resumed	Barclays	Equal Weight	$25
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142

Show Previous Ratings

Today 12:40PM	Applied Materials Earnings, Inflation Data: Still to Come This Week (The Wall Street Journal)
10:46AM	Prasad overruled FDA scientists on Moderna application, STAT says (TipRanks)
08:11AM	Earnings live: Cisco stock drops after outlook disappoints, AppLovin sinks, Equinix surges (Yahoo Finance)
07:27AM	Biotech Turnaround: How Moderna Went From Revenue Collapse to YTD Rally Leader (24/7 Wall St.)
06:40AM	Company News for Feb 12, 2026 (Zacks)
03:09AM	Loading…
03:09AM	CPI Data, Coinbase Earnings, Home Sales: Still to Come This Week (The Wall Street Journal)
Feb-11-26 10:01PM	What To Expect From Moderna's (MRNA) Q4 Earnings (StockStory)
09:23PM	Why the FDA Blocked Modernas New Flu Shot (The Wall Street Journal)
07:28PM	Analyst Report: Moderna, Inc. (Morningstar Research)
06:20PM	Stocks to Watch Wednesday Recap: Netflix, QXO, Moderna, SLB (The Wall Street Journal)
04:45PM	Earnings live: Cisco stock falls after outlook disappoints, McDonald's edges lower, Vertiv soars (Yahoo Finance)
04:36PM	Moderna Stock Sinks on Vaccine Rejection. Company Is Desperately Seeking Clarification. (Barrons.com)
04:36PM	Moderna Stock Sinks on Flu Vaccine Rejection. Company Is Desperately Seeking Clarification. (Barrons.com)
04:35PM	These Stocks Are Todays Movers: Shopify, Moderna, Robinhood, Unity, Vertiv, Generac, Beta Tech, Humana, Micron, and More (Barrons.com)
04:05PM	Moderna Plunges After FDA Rejects Its Messenger-RNA-Based Flu Shot (Investor's Business Daily)
03:13PM	Loading…
03:13PM	Barclays Starts Moderna, Inc. (MRNA) Neutral as Biotech Outlook Improves (Insider Monkey)
02:57PM	Dow still safely above 50,000 but early gains cut, Mattel and Lyft plunge (Proactive)
01:33PM	Mexico enlists Moderna to boost mRNA supply for respiratory diseases (Pharmaceutical Technology)
01:00PM	Moderna's investigational flu vaccine denied FDA review, shares drop (Proactive)
12:29PM	Why Moderna Stock Is Sinking Today (GuruFocus.com)
12:27PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:46AM	FDA declines to review Modernas seasonal flu mRNA vaccine (Pharmaceutical Technology)
10:45AM	MRNA Down Nearly 10% as FDA Refuses to Review Influenza Vaccine BLA (Zacks)
10:44AM	Moderna's work developing seasonal vaccines is 'risky' under current FDA, analyst says (MarketWatch)
10:00AM	Stocks to Watch Wednesday: Netflix, QXO, Moderna, SLB (The Wall Street Journal)
09:44AM	Ancora to oppose WBD-Netflix deal, Kraft Heinz halts split plans (Yahoo Finance Video)
08:24AM	Moderna Stock Sinks. The Puzzling Reason Its Flu Vaccine Was Rejected. (Barrons.com)
08:11AM	Earnings live: Vertiv stock soars on upbeat outlook, Lyft and Robinhood shares tumble, Mattel plunges (Yahoo Finance)
07:05AM	Moderna Stock Sinks. The FDA Delivers a Blow to Its New Flu Vaccine. (Barrons.com)
06:44AM	Moderna shares fall as FDA declines to review new flu vaccine (Reuters)
06:18AM	Loading…
06:18AM	Stocks Climb as January Jobs Growth Eases Economic Concerns (Barchart)
06:18AM	S&P Futures Tick Higher With All Eyes on Key U.S. Jobs Report (Barchart)
06:01AM	These Stocks Are Today's Movers: Moderna, Robinhood, Cloudflare, Lyft, Mattel, Beta Technologies, Gilead, and More (Barrons.com)
05:37AM	Moderna shares slide after FDA vaccine refusal, and other early market movers (MarketWatch)
05:21AM	FDA Refuses To Review Moderna's Influenza Shot Application (Benzinga)
04:33AM	Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill (BioPharma Dive)
03:38AM	Cisco Earnings, Jobs Report, CPI Data: Still to Come This Week (The Wall Street Journal)
01:49AM	FDA refuses to review Modernas mRNA flu vaccine (BioPharma Dive)
Feb-10-26 11:24PM	Wall Street rises to record levels after report showing the jobless rate improved last month (Associated Press Finance)
07:14PM	FDA Refuses to Consider Approving Use of Modernas New Flu Vaccine (The Wall Street Journal)
06:04PM	Moderna Takes It On The Chin After FDA Rejects Its Messenger-RNA-Based Flu Shot (Investor's Business Daily)
05:02PM	Earnings live: Lyft stock tanks on operating loss, Robinhood falls, Ford edges higher (Yahoo Finance)
05:02PM	Earnings live: Lyft stock tanks on operating loss, Mattel stock crashes, Robinhood falls, Ford rises (Yahoo Finance)
02:03PM	Rotation Lifts Energy 23% as Tech Slips Since Oct. 28 (GuruFocus.com)
12:26PM	Moderna, Mexico Partner To Boost Local Vaccine Production (Benzinga)
11:01AM	Jim Cramer on Moderna: "One of the Hottest Stocks in the Market This Year" (Insider Monkey)
10:45AM	Vertex Gears Up to Report Q4 Earnings: Is a Beat in the Cards? (Zacks)
08:15AM	Earnings live: Spotify stock jumps on subscriber growth, CVS earnings beat, BP halts stock buybacks (Yahoo Finance)
07:00AM	Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico (ACCESSWIRE)
06:41AM	What Does the Street Think About Moderna, Inc. (MRNA)? (Insider Monkey)
Feb-09-26 05:45PM	Moderna (MRNA) Laps the Stock Market: Here's Why (Zacks)
04:54PM	Earnings live: Kyndryl and Monday.com stocks tank, Cleveland-Cliffs slides, Chegg drops (Yahoo Finance)
04:08PM	Betting On Moderna? This New Defiance ETF Turns The Volume Up 2X (Benzinga)
01:28PM	Can This Former Pandemic Star Make a Stunning Comeback? (Barchart)
11:38AM	Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts? (Zacks)
11:30AM	Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week (Benzinga)
10:22AM	Zoetis Gears Up to Report Q4 Earnings: Here's What to Expect (Zacks)
08:09AM	Earnings live: Cleveland-Cliffs stock slides after revenue miss, Monday.com stock tanks (Yahoo Finance)
07:51AM	Moderna to Report Q4 Earnings: Is a Beat in Store for the Stock? (Zacks)
Feb-06-26 07:00PM	Super Bowl LX, Coinbase earnings, jobs data & CPI: What to Watch (Yahoo Finance Video)
04:31PM	Earnings live: Amazon, Reddit stocks sink to cap jam-packed earnings week (Yahoo Finance)
12:33PM	Moderna faces $5 billion mRNA patent lawsuit after 'Star Trek' ruling (TheStreet)
10:10AM	Roivant Sciences Q3 Earnings Call Highlights (MarketBeat)
10:10AM	Immunovant Q3 Earnings Call Highlights (MarketBeat)
10:00AM	Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
09:00AM	Here is What to Know Beyond Why Moderna, Inc. (MRNA) is a Trending Stock (Zacks)
08:23AM	Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards? (Zacks)
Feb-05-26 09:29AM	Neurocrine Biosciences to Report Q4 Earnings: What's in the Cards? (Zacks)
08:31AM	AstraZeneca to Report Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-04-26 04:49PM	Tom Gardner's 2026 Outlook: Volatility, Government Scrutiny, and Two AI-Adjacent Stocks (Motley Fool)
01:40PM	Jim Cramer on Moderna: "Even Though the Stock's on the Mend, There Are Many Pharma and Biotech Names That I Like Better" (Insider Monkey)
07:27AM	GSK Q4 Earnings Call Highlights (MarketBeat)
Feb-03-26 05:10PM	Amgen (AMGN) Q4 Earnings and Revenues Beat Estimates (Zacks)
10:37AM	Are Wall Street Analysts Bullish on Moderna Stock? (Barchart)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
08:30AM	CRSP to Report Q4 Earnings: Is a Beat in Store for the Stock? (Zacks)
07:56AM	New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings (Zacks)
Feb-02-26 05:50PM	Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jan-30-26 08:47AM	Viking Therapeutics to Report Q4 Earnings: Here's What to Know (Zacks) -5.95%
07:30AM	Dr. David Berman to Join Moderna as Chief Development Officer (ACCESSWIRE)
Jan-29-26 12:42PM	Jim Cramer on Moderna: "We Have to Wait and See" (Insider Monkey)
08:16AM	3 ETFs Catapulting Beyond the S&P to Start the Year (MarketBeat)
05:20AM	Moderna holds a garage sale; Roche defends obesity drug data (BioPharma Dive)
Jan-28-26 09:05PM	This Stock Is Already Up 58% This Year. Is It a Buy? (Motley Fool)
11:24AM	Amgen Set to Report Q4 Earnings: What Investors Should Know (Zacks)
Jan-27-26 10:50AM	Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks (PR Newswire) -5.29%
08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jan-26-26 05:50PM	Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
11:15AM	Moderna (MRNA) Stock Pulls Back After Recent Strength (Benzinga)
07:00AM	Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026 (ACCESSWIRE)
Jan-25-26 09:01AM	Hecla Mining, Moderna, And Micron Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio? (Benzinga)
Jan-24-26 07:00AM	MarketBeat Week in Review - 01/19 - 01/23 (MarketBeat)
Jan-23-26 01:55PM	Silver Breaks $101, Intel Stock Plunges 17%: What's Moving Markets Friday? (Benzinga) -6.09%
11:10AM	Stock Market Falls, Recovers On Trump's Greenland Shifts; Intel, Netflix, Tesla Key Movers: Weekly Review (Investor's Business Daily)
Jan-22-26 05:53PM	Baseline characteristics in Moderna cancer vaccine 'misleading': Leerink's Dr. Mani Foroohar (CNBC TV)
05:02PM	These Stocks Are Today's Movers: Intel, GE Aerospace, Moderna, Abbott, Arista Networks, Mobileye, McCormick, and More (Barrons.com)
04:09PM	Moderna Stock Soars. This Has Sparked a Rally. (Barrons.com)
02:31PM	Biotech stocks are among today's winners (MarketWatch)
02:08PM	Dow, S&P 500, Nasdaq rise, mortgage rates tick higher (Yahoo Finance Video)
12:27PM	Can Elevance Offset Rising Expenses in Q4 With Higher Premiums? (Zacks)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM
Hussain Abbas	Director	Jun 11 '25	Sale	28.00	312	8,736	580	Jun 12 04:22 PM
Hussain Abbas	Director	Jun 11 '25	Proposed Sale	28.00	312	8,736		Jun 11 10:06 AM
Bancel Stephane	Chief Executive Officer	Mar 03 '25	Buy	31.22	160,314	5,004,318	9,210,686	Mar 04 04:27 PM
SAGAN PAUL	Director	Mar 03 '25	Buy	31.76	31,620	1,004,251	312,027	Mar 04 04:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your FINVIZ experience